Mon, 02 Oct 2023 12:04:12 GMT (1696248252810)
709ee95582598429b00a59d2abab41b65c2ae2db
ea2afc069eda94e93559a101774a741c91bc06fb
Chattanooga native leads NIH clinical trial for COVID-19 treatment, locals share thoughts
![One of the study team leaders for the trial is Davey Smith, M.D., of the University of California, San Diego. He is originally from Middle Valley and is a graduate of Red Bank High School and the University of Tennessee at Chattanooga.{ } [Image: Davey Smith]](/resources/media2/16x9/full/1015/center/80/b35e9105-973d-4e4f-b241-80e39ad0fe6a-large16x9_Daveyinhood.JPG)
![One of the study team leaders for the trial is Davey Smith, M.D., of the University of California, San Diego. He is originally from Middle Valley and is a graduate of Red Bank High School and the University of Tennessee at Chattanooga.{ } [Image: Davey Smith]](/resources/media/99fd6fc1-6ee4-4d2f-83ef-639dfcc4ea19-medium16x9_DaveyHeadshot1.png?1589639526097)
![On Thursday the National Institutes of Health announced a clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). [Image: Davey Smith]{ }](/resources/media/e16ed75d-67c9-4bc8-b225-1ea584f23d10-medium16x9_Screenshot2020051607.07.36.png?1589639526794)
One of the study team leaders for the trial is Davey Smith, M.D., of the University of California, San Diego. He is originally from Middle Valley and is a graduate of Red Bank High School and the University of Tennessee at Chattanooga. [Image: Davey Smith]
Loading ...